Immunotherapies for Prostate Cancer

Image

Main Focus Areas:

  • Interrogation of molecular mechanisms underlying race-related prostate tumor aggressiveness
  • Development of biomarkers based on mechanisms of race-related tumor aggressiveness to better predict how aggressive a patient’s prostate cancer will be
  • Modulation of mechanisms of race-related tumor aggressiveness to better treat patients whose prostate cancer is dependent on these mechanisms
  • Determination of the importance of mechanisms of race-related prostate tumor aggressiveness for response to current therapeutic strategies
  • Establishment of preclinical models of prostate cancer from racially and ethnically diverse patient populations
  • Identification of biological, lifestyle, social and structural interactions that drive prostate cancer disparities

Key Grants & Publications: